Abzena
PrivateLast Round
Private Equity
Mar 31, 2022
Est. Valuation
$44.4M
Total Funding Raised
$126.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Abzena is a biotechnology company that provides integrated discovery, development, and manufacturing services for biologics and antibody-drug conjugates (ADCs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abzena Comparables
Compare Abzena with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MabPlex International | 88% | |
| MabPlex | 82% | |
| JSR Life Sciences | 80% |
Abzena Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Mar 31, 2022 | ||||
| Growth Equity | Jul 28, 2020 | ||||
| Take Private | Aug 17, 2018 | ||||
| Follow-on Offering | Apr 5, 2017 | ||||
| Private Placement | Nov 24, 2015 | ||||
IPO | Jul 10, 2014 |
Key People
Founding team and executive leadership
Abzena Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invesco Ltd. | Follow-on Offering |
| Biospring Partners | Private Equity, Growth Equity |
| Cavendish | IPO |
| Woodford Investment Management | IPO, Follow-on Offering |
| Imperial Innovations | IPO, Series A |
| Invesco Perpetual | Series A, IPO |
| Welsh, Carson, Anderson & Stowe | Private Equity, Take Private |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 852, 2.5x the trailing average.
- Jul 13, 2026
Open roles increased to 146, 33% of headcount.
Recent news
Latest coverage and updates
- attends_eventJul 15, 2026
Abzena PLC attended event Outsourced Pharma Capabilities Update on Jun 16th '26.
Abzena Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access